243 related articles for article (PubMed ID: 21294897)
1. Respective implications of glutamate decarboxylase antibodies in stiff person syndrome and cerebellar ataxia.
Manto MU; Hampe CS; Rogemond V; Honnorat J
Orphanet J Rare Dis; 2011 Feb; 6():3. PubMed ID: 21294897
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies to 65kDa glutamate decarboxylase induce epitope specific effects on motor and cognitive functions in rats.
Hampe CS; Petrosini L; De Bartolo P; Caporali P; Cutuli D; Laricchiuta D; Foti F; Radtke JR; Vidova V; Honnorat J; Manto M
Orphanet J Rare Dis; 2013 Jun; 8():82. PubMed ID: 23738610
[TBL] [Abstract][Full Text] [Related]
3. Cerebellar ataxia and glutamic acid decarboxylase antibodies: immunologic profile and long-term effect of immunotherapy.
Ariño H; Gresa-Arribas N; Blanco Y; Martínez-Hernández E; Sabater L; Petit-Pedrol M; Rouco I; Bataller L; Dalmau JO; Saiz A; Graus F
JAMA Neurol; 2014 Aug; 71(8):1009-16. PubMed ID: 24934144
[TBL] [Abstract][Full Text] [Related]
4. Human Stiff person syndrome IgG-containing high-titer anti-GAD65 autoantibodies induce motor dysfunction in rats.
Hansen N; Grünewald B; Weishaupt A; Colaço MN; Toyka KV; Sommer C; Geis C
Exp Neurol; 2013 Jan; 239():202-9. PubMed ID: 23099416
[TBL] [Abstract][Full Text] [Related]
5. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.
Saiz A; Blanco Y; Sabater L; González F; Bataller L; Casamitjana R; Ramió-Torrentà L; Graus F
Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732
[TBL] [Abstract][Full Text] [Related]
6. Anti-GAD Antibodies and the Cerebellum: Where Do We Stand?
Manto M; Mitoma H; Hampe CS
Cerebellum; 2019 Apr; 18(2):153-156. PubMed ID: 30343467
[TBL] [Abstract][Full Text] [Related]
7. Analysis of GAD65 autoantibodies in Stiff-Person syndrome patients.
Raju R; Foote J; Banga JP; Hall TR; Padoa CJ; Dalakas MC; Ortqvist E; Hampe CS
J Immunol; 2005 Dec; 175(11):7755-62. PubMed ID: 16301686
[TBL] [Abstract][Full Text] [Related]
8. Neurological Syndromes Associated with Anti-GAD Antibodies.
Dade M; Berzero G; Izquierdo C; Giry M; Benazra M; Delattre JY; Psimaras D; Alentorn A
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32456344
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to inhibitory synaptic proteins in neurological syndromes associated with glutamic acid decarboxylase autoimmunity.
Gresa-Arribas N; Ariño H; Martínez-Hernández E; Petit-Pedrol M; Sabater L; Saiz A; Dalmau J; Graus F
PLoS One; 2015; 10(3):e0121364. PubMed ID: 25774787
[TBL] [Abstract][Full Text] [Related]
10. Clinical and Immunologic Investigations in Patients With Stiff-Person Spectrum Disorder.
Martinez-Hernandez E; Ariño H; McKeon A; Iizuka T; Titulaer MJ; Simabukuro MM; Lancaster E; Petit-Pedrol M; Planagumà J; Blanco Y; Harvey RJ; Saiz A; Graus F; Dalmau J
JAMA Neurol; 2016 Jun; 73(6):714-20. PubMed ID: 27065452
[TBL] [Abstract][Full Text] [Related]
11. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients.
Honnorat J; Saiz A; Giometto B; Vincent A; Brieva L; de Andres C; Maestre J; Fabien N; Vighetto A; Casamitjana R; Thivolet C; Tavolato B; Antoine J; Trouillas P; Graus F
Arch Neurol; 2001 Feb; 58(2):225-30. PubMed ID: 11176960
[TBL] [Abstract][Full Text] [Related]
12. Stiff-person syndrome associated with cerebellar ataxia and high glutamic acid decarboxylase antibody titer.
Kono S; Miyajima H; Sugimoto M; Suzuki Y; Takahashi Y; Hishida A
Intern Med; 2001 Sep; 40(9):968-71. PubMed ID: 11579968
[TBL] [Abstract][Full Text] [Related]
13. Pathogenic Roles of Glutamic Acid Decarboxylase 65 Autoantibodies in Cerebellar Ataxias.
Mitoma H; Manto M; Hampe CS
J Immunol Res; 2017; 2017():2913297. PubMed ID: 28386570
[TBL] [Abstract][Full Text] [Related]
14. Primary DQ effect in the association between HLA and neurological syndromes with anti-GAD65 antibodies.
Muñiz-Castrillo S; Ambati A; Dubois V; Vogrig A; Joubert B; Rogemond V; Picard G; Lin L; Fabien N; Mignot E; Honnorat J
J Neurol; 2020 Jul; 267(7):1906-1911. PubMed ID: 32152690
[TBL] [Abstract][Full Text] [Related]
15. Epitope spreading and a varying but not disease-specific GAD65 antibody response in Type I diabetes. The Childhood Diabetes in Finland Study Group.
Söhnlein P; Müller M; Syren K; Hartmann U; Böhm BO; Meinck HM; Knip M; Akerblom HK; Richter W
Diabetologia; 2000 Feb; 43(2):210-7. PubMed ID: 10753043
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity.
Saiz A; Arpa J; Sagasta A; Casamitjana R; Zarranz JJ; Tolosa E; Graus F
Neurology; 1997 Oct; 49(4):1026-30. PubMed ID: 9339684
[TBL] [Abstract][Full Text] [Related]
17. Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases.
Manto MU; Laute MA; Aguera M; Rogemond V; Pandolfo M; Honnorat J
Ann Neurol; 2007 Jun; 61(6):544-51. PubMed ID: 17600364
[TBL] [Abstract][Full Text] [Related]
18. Neurological disorders associated with glutamic acid decarboxylase antibodies: a Brazilian series.
Fernandes M; Munhoz RP; Carrilho PE; Arruda WO; Lorenzoni PJ; Scola RH; Werneck LC; Teive HA
Arq Neuropsiquiatr; 2012 Sep; 70(9):657-61. PubMed ID: 22990719
[TBL] [Abstract][Full Text] [Related]
19. Human B cells secreting immunoglobulin G to glutamic acid decarboxylase-65 from a nondiabetic patient with multiple autoantibodies and Graves' disease: a comparison with those present in type 1 diabetes.
Tremble J; Morgenthaler NG; Vlug A; Powers AC; Christie MR; Scherbaum WA; Banga JP
J Clin Endocrinol Metab; 1997 Aug; 82(8):2664-70. PubMed ID: 9253351
[TBL] [Abstract][Full Text] [Related]
20. Anti-GAD positive stiff-person syndrome and cerebellar ataxia: two treatable conditions that clinicians should be aware of.
Ferraz HB
Arq Neuropsiquiatr; 2012 Sep; 70(9):655-6. PubMed ID: 22990718
[No Abstract] [Full Text] [Related]
[Next] [New Search]
